Shareholding14 May 2026, 08:35 am
Milly Chetan Lalseta Acquires 0.26% Stake in Aptus Pharma
AI Summary
Milly Chetan Lalseta acquired 18,000 equity shares of Aptus Pharma Limited via off-market inter-se transfer among Promoter Group on May 11, 2026, increasing her stake from 8.38% to 8.64%. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The equity share capital of Aptus Pharma Limited remains at 68,60,000 shares of ₹10 each after the acquisition.
Key Highlights
- Milly Chetan Lalseta acquired 18,000 shares of Aptus Pharma.
- Stake increased from 8.38% to 8.64% after the acquisition.
- Acquisition occurred via off-market inter-se transfer.
- Transaction took place on May 11, 2026.
- Disclosure made under SEBI Takeover Regulations.
Price Impact
More from APPL